Practices that combine electronics with biology have been recently dubbed "bioelectronics." The United States Institutes of Health has awarded $20 million towards research in this field as various companies and research groups around the globe begin to delve into the science behind it all. Companies such as Google, General Electric, and GlaxoSmithKline have all shown an interest in the field.
Tracey says the premise behind the technology is a novel one. Bioelectronics seeks to manipulate the neural circuits behind the release of certain problematic molecules while conventional medicine looks to tackle the very presence of the molecules using drugs.